( in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
1114
1022.38
1224.06
1354.98
Total Expenditure
976.8
856.64
1032.7
1115.41
PBIDT (Excl OI)
137.2
165.74
191.36
239.57
Other Income
8.12
8.73
13.01
13.32
Operating Profit
145.32
174.47
204.36
252.89
Exceptional Items
NA
NA
NA
NA
PBDT
142.6
171.67
201.62
250.7
Depreciation
18.98
16.09
15.1
12.67
Profit Before Tax
123.62
155.58
186.52
238.03
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
91.35
115.2
138
175.6
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
91.35
115.2
138
175.6
Minority Interest
1.19
NA
0.4
0.29
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
92.56
115.2
138.39
175.9
Equity Capital
197.25
197.25
197.25
197.25
Calculated EPS
2.34
2.92
3.50
4.45
Calculated EPS (Annualised)
9.38
11.68
14.03
17.83
No of Public Share Holdings
11737019
11737019
11737019
11737219
% of Public Share Holdings
29.75
29.75
29.75
29.75
PBIDTM% (Excl OI)
12.31
16.21
15.63
17.68
PBIDTM%
13.04
17.06
16.69
18.66
PBDTM%
12.80
16.79
16.47
18.50
PBTM%
11.09
15.21
15.23
17.56